Literature DB >> 19824047

Combined effects of chronic nicotine and acute virus exposure on neurotrophin expression in rat lung.

Fernando Urrego1, Mario Scuri, Alexander Auais, Lida Mohtasham, Giovanni Piedimonte.   

Abstract

Strong epidemiologic evidence indicates that tobacco smoke influences frequency and severity of respiratory infections. Previously, we have shown that infection with respiratory syncytial virus upregulates expression of neurotrophic factors and receptors in the lungs, but the effect of tobacco exposure on neurotrophins is unknown. Therefore, we first sought to determine the expression of neurotrophic pathways in lungs of rats chronically exposed to nicotine, and then we studied the interactions between pollution and infection by inoculating virus after nicotine exposure. Expression of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor, of their high-affinity tyrosine kinase receptors (trkA and trkB, respectively), and of the low-affinity receptor p75(NTR) was measured in the lungs of nicotine-exposed rats both at the mRNA level by reverse-transcription polymerase chain reaction and at the protein level by enzyme-linked immunoassay. Nicotine increased NGF expression both at the mRNA and protein level and also created a receptor imbalance deriving from increased expression of the pro-inflammatory p75(NTR) receptor without any concomitant change in the high-affinity trkA receptor. Viral infection after chronic nicotine exposure exerted an additive effect on NGF expression, and resulted in exaggerated neurogenic airway inflammation that was abolished by selective inhibition. In conclusion, nicotine levels comparable to those found in smokers are per se able to upregulate the expression of critical neurotrophic molecules in the respiratory tract, and combination of an acute infection following chronic nicotine exposure produces more severe neurotrophic dysregulation and neurogenic-mediated inflammation compared to either infection or nicotine alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19824047      PMCID: PMC3632456          DOI: 10.1002/ppul.21099

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  42 in total

Review 1.  Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae.

Authors:  G Piedimonte
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

Review 2.  Effects of cigarette smoke on the immune system.

Authors:  Mohan Sopori
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

3.  A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways.

Authors:  G Piedimonte; K A King; N L Holmgren; P J Bertrand; M M Rodriguez; R L Hirsch
Journal:  Pediatr Res       Date:  2000-03       Impact factor: 3.756

4.  The effect of passive smoking on the development of respiratory syncytial virus bronchiolitis.

Authors:  F Gürkan; A Kiral; E Dağli; F Karakoç
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

5.  Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats.

Authors:  K A King; C Hu; M M Rodriguez; R Romaguera; X Jiang; G Piedimonte
Journal:  Am J Respir Cell Mol Biol       Date:  2001-02       Impact factor: 6.914

6.  Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons.

Authors:  X Carbonell-Estrany; J Quero
Journal:  Pediatr Infect Dis J       Date:  2001-09       Impact factor: 2.129

Review 7.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

8.  Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus.

Authors:  Katrin Wedde-Beer; Chengping Hu; Maria M Rodriguez; Giovanni Piedimonte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-05       Impact factor: 5.464

9.  Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs.

Authors:  Chengping Hu; Katrin Wedde-Beer; Alexander Auais; Maria M Rodriguez; Giovanni Piedimonte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-08       Impact factor: 5.464

10.  Neuroanatomical relationships of substance P-immunoreactive intrapulmonary C-fibers and nicotinic cholinergic receptors.

Authors:  Ozra Dehkordi; Jed E Rose; Kannan V Balan; Prabha Kc; Richard M Millis; Annapurni Jayam-Trouth
Journal:  J Neurosci Res       Date:  2009-05-15       Impact factor: 4.164

View more
  7 in total

1.  Neurokinin-neurotrophin interactions in airway smooth muscle.

Authors:  Lucas W Meuchel; Alecia Stewart; Dan F Smelter; Amard J Abcejo; Michael A Thompson; Syed I A Zaidi; Richard J Martin; Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-22       Impact factor: 5.464

Review 2.  Neurotrophins in lung health and disease.

Authors:  Ys Prakash; Michael A Thompson; Lucas Meuchel; Christina M Pabelick; Carlos B Mantilla; Syed Zaidi; Richard J Martin
Journal:  Expert Rev Respir Med       Date:  2010-06       Impact factor: 3.772

Review 3.  Brain-derived neurotrophic factor in the airways.

Authors:  Y S Prakash; Richard J Martin
Journal:  Pharmacol Ther       Date:  2014-02-19       Impact factor: 12.310

4.  Prenatal nicotinic exposure augments cardiorespiratory responses to activation of bronchopulmonary C-fibers.

Authors:  Jianguo Zhuang; Lei Zhao; Na Zang; Fadi Xu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-03-06       Impact factor: 6.011

5.  Nicotine stimulates nerve growth factor in lung fibroblasts through an NFκB-dependent mechanism.

Authors:  Cherry Wongtrakool; Kora Grooms; Kaiser M Bijli; Kristina Crothers; Anne M Fitzpatrick; C Michael Hart
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

6.  Seasonal Timing of Infant Bronchiolitis, Apnea and Sudden Unexplained Infant Death.

Authors:  Chantel D Sloan; Tebeb Gebretsadik; Christian Rosas-Salazar; Pingsheng Wu; Kecia N Carroll; Edward Mitchel; Larry J Anderson; Emma K Larkin; Tina V Hartert
Journal:  PLoS One       Date:  2016-07-12       Impact factor: 3.240

Review 7.  COVID-19 breakthroughs: separating fact from fiction.

Authors:  Paraminder Dhillon; Manuel Breuer; Natasha Hirst
Journal:  FEBS J       Date:  2020-07-05       Impact factor: 5.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.